Sign In
Buy IMGN
$31.23
+0 (+0%)
At Close: May 08, 2024
Why ImmunoGen Stock Is Flying High Today
01:25pm, Wednesday, 01'st Dec 2021
The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cancer.
ImmunoGen Reveals Topline Results from SORAYA Trial; Shares Jump
12:38pm, Wednesday, 01'st Dec 2021 Smarter Analyst
This article was originally published on TipRanks.com ImmunoGen Inc. The post ImmunoGen Reveals Topline Results from SORAYA Trial; Shares Jump appeared first on Smarter Analyst .
ImmunoGen (IMGN) Surges on Successful Ovarian Cancer Study
11:30am, Wednesday, 01'st Dec 2021
ImmunoGen (IMGN) reports successful completion of a pivotal study evaluating its lead pipeline candidate as monotherapy in certain ovarian cancer patients previously treated with Avastin.
A Peek Into The Markets: US Stock Futures Higher Ahead Of ADP, Manufacturing Data
11:09am, Wednesday, 01'st Dec 2021 Benzinga
Pre-open movers
U.S. stock futures traded higher in early pre-market trade after recording gains in the previous session. Investors are awaiting earnings results from G-III Apparel Group, Ltd. (NASD
Price T Rowe Associates Inc. MD Grows Position in ImmunoGen, Inc. (NASDAQ:IMGN)
10:04am, Wednesday, 01'st Dec 2021 Dakota Financial News
Price T Rowe Associates Inc. MD boosted its position in ImmunoGen, Inc. (NASDAQ:IMGN) by 3.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 86,902 shares of the biotechnology companys stock after purchasing an additional 3,116 shares during the period. Price T Rowe Associates Inc. MDs []
ImmunoGen price outlook as shares spike 30% on positive mirvetuximab data
11:57pm, Tuesday, 30'th Nov 2021 Invezz
On Tuesday, ImmunoGen Inc. (NASDAQ:IMGN) shares surged by nearly 30% after reporting positive mirvetuximab data in ovarian cancer. The company announced positive top-line data from the SORAYA trial, w
Hot Stocks: DDS leads sector lower; IMGN, OLMA move on clinical data; AIP sets post-IPO high; BZUN hits low
10:36pm, Tuesday, 30'th Nov 2021 Seeking Alpha
Why ImmunoGen Stock Soared Today
09:33pm, Tuesday, 30'th Nov 2021 The Motley Fool
The cancer-fighting specialist's new antibody treatment could be a gamechanger.
ImmunoGen slips on $175M common stock offering
09:11pm, Tuesday, 30'th Nov 2021 Seeking AlphaImmunoGen price outlook as shares spike 30% on positive mirvetuximab data
06:57pm, Tuesday, 30'th Nov 2021
On Tuesday, ImmunoGen Inc. (NASDAQ:IMGN) shares surged by nearly 30% after reporting positive mirvetuximab data in ovarian cancer. The company announced positive top-line data from the SORAYA trial, w
List of Penny Stocks to Watch While The Stock Market is Down Today
06:16pm, Tuesday, 30'th Nov 2021 PennyStocks
Here's three penny stocks to watch with the market down today
The post List of Penny Stocks to Watch While The Stock Market is Down Today appeared first on Penny Stocks to Buy, Picks, News and Informa
These 2 Nasdaq Biotechs Are Bucking the Market Downtrend
05:48pm, Tuesday, 30'th Nov 2021 The Motley Fool
Wall Street is having a bad day, but shareholders in these companies are celebrating.
Why ImmunoGen Stock Soared Today
04:33pm, Tuesday, 30'th Nov 2021
The cancer-fighting specialist's new antibody treatment could be a gamechanger.
List of Penny Stocks to Watch While The Stock Market is Down Today
01:16pm, Tuesday, 30'th Nov 2021
Here's three penny stocks to watch with the market down today The post List of Penny Stocks to Watch While The Stock Market is Down Today appeared first on Penny Stocks to Buy, Picks, News and Informa
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
01:12pm, Tuesday, 30'th Nov 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-Operative Administration
Cumber
